Prostate Cancer Reports


Volume 2 Number 10
 October 2014

Home > Prostate Cancer Reports > Volume 2 - Year 2014 > Number 10, October 2014

CONTENTS



Detection, Prevention, Screening
Diagnosis and evaluation
Etiology and pathogenesis
Integrative medicine
Overall management
Prognosis and outcome
Psychosocial aspects
Staging


DETECTION, PREVENTION, SCREENING



Le JD, Tan N, Shkolyar E, Lu DY, Kwan L, Marks LS, Huang J, Margolis DJ, Raman SS, Reiter RE.
Multifocality and Prostate Cancer Detection by Multiparametric Magnetic Resonance Imaging: Correlation with Whole-mount Histopathology.
Eur Urol. 2014 Sep 22. pii: S0302-2838(14)00891-4. doi: 10.1016/j.eururo.2014.08.079. [Epub ahead of print]
Abstract | Related citations

DIAGNOSIS AND EVALUATION



Glazer DI, Davenport MS, Khalatbari S, Cohan RH, Ellis JH, Caoili EM, Stein EB, Childress JC, Masch WR, Brown JM, Mollard BJ, Montgomery JS, Palapattu GS, Francis IR.
Mass-like peripheral zone enhancement on CT is predictive of higher-grade (Gleason 4 + 3 and higher) prostate cancer.
Abdom Imaging. 2014 Sep 6. [Epub ahead of print]
Abstract | Related citations


Hong SK, Vertosick E, Sjoberg DD, Scardino PT, Eastham JA.
Insignificant disease among men with intermediate-risk prostate cancer.
World J Urol. 2014 Sep 27. [Epub ahead of print]
Abstract | Related citations


Zhang Q, Sun LJ, Qi J, Yang ZG, Huang T, Huo RC.
Periprostatic adiposity measured on magnetic resonance imaging correlates with prostate cancer aggressiveness.
Urol J. 2014 Sep 6;11(4):1793-9.
Abstract | Full text | Related citations

ETIOLOGY AND PATHOGENESIS



Klap J, Schmid M, Loughlin KR.
The relationship between total testosterone levels and prostate cancer: A review of the continuing controversy.
J Urol. 2014 Sep 23. pii: S0022-5347(14)04490-5. doi: 10.1016/j.juro.2014.07.123. [Epub ahead of print]
Abstract | Related citations


Park SW, Kim JY, Kim YS, Lee SJ, Lee SD, Chung MK.
A milk protein, casein, as a proliferation promoting factor in prostate cancer cells.
World J Mens Health. 2014 Aug;32(2):76-82. doi: 10.5534/wjmh.2014.32.2.76. Epub 2014 Aug 26.
Abstract | Full text | Related citations

INTEGRATIVE MEDICINE



Fair WR, Fleshner NE, Heston W.
Cancer of the prostate: a nutritional disease?
Urology. 1997 Dec;50(6):840-8.
Abstract | 1Full text | Related citations


Ahmad A, Biersack B, Li Y, Bao B, Kong D, Ali S, Banerjee S, Sarkar FH.
Perspectives on the role of isoflavones in prostate cancer.
AAPS J. 2013 Oct;15(4):991-1000. doi: 10.1208/s12248-013-9507-1. Epub 2013 Jul 4.
Abstract | Full text | Related citations


Leitzmann MF, Stampfer MJ, Michaud DS, Augustsson K, Colditz GC, Willett WC, Giovannucci EL.
Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer.
Am J Clin Nutr. 2004 Jul;80(1):204-16.
Abstract | Full text | Related citations


Posadzki P, Lee MS, Onakpoya I, Lee HW, Ko BS, Ernst E.
Dietary supplements and prostate cancer: a systematic review of double-blind, placebo-controlled randomised clinical trials.
Maturitas. 2013 Jun;75(2):125-30. doi: 10.1016/j.maturitas.2013.03.006. Epub 2013 Apr 6.
Abstract | Full text | Related citations

OVERALL MANAGEMENT



Moran BJ, DeRose P, Hsu IC, Abdel-Wahab M, Arterbery VE, Ciezki JP, Frank SJ, Mohler JL, Rosenthal SA, Rossi CJ Jr, Yamada Y, Merrick GS.
ACR Appropriateness CriteriaŽ definitive external beam irradiation in stage T1 and T2 prostate cancer.
Am J Clin Oncol. 2011 Dec;34(6):636-47. doi: 10.1097/COC.0b013e3182354a65.
Abstract | Full text | Related citations


Nguyen PL, Aizer A, Assimos DG, D'Amico AV, Frank SJ, Gottschalk AR, Gustafson GS, Hsu IC, McLaughlin PW, Merrick G, Rosenthal SA, Showalter TN, Taira AV, Vapiwala N, Yamada Y, Davis BJ; American College of Radiology, Expert Panel on Radiation OncologyProstate.
ACR Appropriateness CriteriaŽ Definitive External-Beam Irradiation in stage T1 and T2 prostate cancer.
Am J Clin Oncol. 2014 Jun;37(3):278-88. doi: 10.1097/COC.0000000000000049.
Abstract | Full text | Related citations

PROGNOSIS AND OUTCOME



Boorjian SA, Eastham JA, Graefen M, Guillonneau B, Karnes RJ, Moul JW, Schaeffer EM, Stief C, Zorn KC.
A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes.
Eur Urol. 2012 Apr;61(4):664-75. doi: 10.1016/j.eururo.2011.11.053. Epub 2011 Dec 7.
Abstract | Full text | Related citations


Daskivich TJ, Fan KH, Koyama T, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Stanford JL, Stroup AM, Litwin MS, Penson DF.
Prediction of Long-term Other-cause Mortality in Men With Early-stage Prostate Cancer: Results From the Prostate Cancer Outcomes Study.
Urology. 2014 Sep 23. pii: S0090-4295(14)00703-1. doi: 10.1016/j.urology.2014.07.003. [Epub ahead of print]
Abstract | Related citations


Hatzichristou D.
Post-radical prostatectomy erectile function: the five Ws and the H.
Eur Urol. 2012 Aug;62(2):287-9. doi: 10.1016/j.eururo.2012.05.039. Epub 2012 May 22.
Abstract | Full text | Related citations


Hatzimouratidis K, Burnett AL, Hatzichristou D, McCullough AR, Montorsi F, Mulhall JP.
Phosphodiesterase type 5 inhibitors in postprostatectomy erectile dysfunction: a critical analysis of the basic science rationale and clinical application.
Eur Urol. 2009 Feb;55(2):334-47. doi: 10.1016/j.eururo.2008.10.028. Epub 2008 Oct 21
Abstract | Full text | Related citations


Lepor H.
Radical prostatectomy for long-term functional and oncologic outcomes.
Eur Urol. 2012 Apr;61(4):676-8. doi: 10.1016/j.eururo.2012.01.004. Epub 2012 Jan 11.
Abstract | Full text | Related citations


Martin NE, Massey L, Stowell C, Bangma C, Briganti A, Bill-Axelson A, Blute M, Catto J, Chen RC, D'Amico AV, Feick G, Fitzpatrick JM, Frank SJ, Froehner M, Frydenberg M, Glaser A, Graefen M, Hamstra D, Kibel A, Mendenhall N, Moretti K, Ramon J, Roos I, Sandler H, Sullivan FJ, Swanson D, Tewari A, Vickers A, Wiegel T, Huland H.
Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer.
Eur Urol. 2014 Sep 15. pii: S0302-2838(14)00845-8. doi: 10.1016/j.eururo.2014.08.075. [Epub ahead of print]
Abstract | Related citations


Salonia A, Burnett AL, Graefen M, Hatzimouratidis K, Montorsi F, Mulhall JP, Stief C.
Prevention and management of postprostatectomy sexual dysfunctions part 2: recovery and preservation of erectile function, sexual desire, and orgasmic function.
Eur Urol. 2012 Aug;62(2):273-86. doi: 10.1016/j.eururo.2012.04.047. Epub 2012 May 3.
Abstract | Full text | Related citations


Sugihara T, Yu C, Kattan MW, Yasunaga H, Ihara H, Onozawa M, Hinotsu S, Akaza H.
Long-term Survival of Extremely Advanced Prostate Cancer Patients Diagnosed with Prostate-specific Antigen over 500 ng/ml.
Jpn J Clin Oncol. 2014 Sep 19. pii: hyu142. [Epub ahead of print]
Abstract | Related citations

PSYCHOSOCIAL ASPECTS



Punnen S, Cowan JE, Chan JM, Carroll PR, Cooperberg MR.
Long-term Health-related Quality of Life After Primary Treatment for Localized Prostate Cancer: Results from the CaPSURE Registry.
Eur Urol. 2014 Sep 18. pii: S0302-2838(14)00844-6. doi: 10.1016/j.eururo.2014.08.074. [Epub ahead of print]
Abstract | Related citations

STAGING



Kim L, Min M, Roos D, Nguyen L, Yeoh E.
Are staging investigations being overused in patients with low and intermediate risk prostate cancer?
J Med Imaging Radiat Oncol. 2014 Sep 4. doi: 10.1111/1754-9485.12234. [Epub ahead of print]
Abstract | Related citations